Johnson & Johnson
JNJ
New York Stock Exchange. Currency in USD
175.48 -0.19 ( -0.11% )
Market Cap.
458.79B
Beta (5Y monthly)
0.57
Price/Earnings
17.83
EPS (TTM)
9.94
Forward Dividend
4.52 (2.51%)
Ex-Dividend Date
Nov 22, 2022
Volume
5.52M
1y Target Est.
184.75
Day's Range
52 Week's Range
Historical Summary
Performance
1 Month
-0.41%
YTD
2.58%
1Y
4.31%
2Y
13.57%
6.57% ann.
3Y
20.73%
6.48% ann.
5Y
23.77%
4.36% ann.
10Y
148.45%
9.53% ann.
EPS growth
1Y
4.30%
2Y
23.48%
11.13% ann.
3Y
13.34%
4.26% ann.
5Y
39.22%
6.84% ann.
10Y
96.83%
7.01% ann.
20Y
362.33%
7.96% ann.
Share Buybacks
3 Months
0.25%
6 Months
0.20%
1Y
0.51%
2Y
0.30%
3Y
0.32%
5Y
2.79%
10Y
5.56%
20Y
12.07%
About Johnson & Johnson
Sector
Healthcare
Industry
Drug Manufacturers-General
Website
https://www.jnj.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
2.63B
Employees
141700
Address
One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933
Latest news

Wall Street Breakfast: What Moved Markets
Listen on the go! A daily podcast of Wall Street Breakfast will be available this...
By Seeking Alpha - 6 weeks ago

FDA Delays Decision on AstraZeneca (AZN), Merck's Lynparza sNDA
The FDA extends the review period of AstraZeneca (AZN)/Merck's filing seeking label expansion for Lynparza's...
By Zacks Investment Research - 7 weeks ago

Want $250 in Passive Income? Buy These 2 Dividend Kings and Wait
These companies will work hard to grow your base of passive income.
By The Motley Fool - 7 weeks ago

Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?
There's a lot more ahead for these market giants.
By The Motley Fool - 7 weeks ago

5 Phenomenal Stocks in Warren Buffett's Secret Portfolio That Are Screaming Buys in 2023
The Oracle of Omaha's $5.9 billion hidden portfolio is home to five amazing companies that...
By The Motley Fool - 7 weeks ago

Zacks Industry Outlook Highlights Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca
Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca have been highlighted in this Industry Outlook...
By Zacks Investment Research - 7 weeks ago

4 Large Drug Stocks to Watch in a Booming Industry
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap...
By Zacks Investment Research - 7 weeks ago

2 Top Dividend Kings to Buy for the Long Haul
No matter how much changes, these two healthcare giants keep performing.
By The Motley Fool - 7 weeks ago